Literature DB >> 22747478

A recurrent fibronectin glomerulopathy in a renal transplant patient: a case report.

Yasuhiro Otsuka1, Asami Takeda, Keiji Horike, Daijyo Inaguma, Norihiko Goto, Yoshihiko Watarai, Kazuharu Uchida, Michael J Mihatsch, Kensuke Joh, Kunio Morozumi.   

Abstract

Fibronectin glomerulopathy (FNG) is a rare, autosomal dominant renal disease with massive mesangial, and subendothelial fibronectin deposits. It presents proteinuria, often in the nephrotic range in the third to fourth decade, and slow progression to end-stage renal disease. The risk of recurrent disease in renal allograft is uncertain. A Japanese female with end-stage renal disease because of unknown origin received a renal transplant and was referred with proteinuria and mild deterioration of renal function four months after transplantation. Five allograft biopsies were underwent from one h to 12 months after the transplantation, including a biopsy 19 d after the transplantation, which revealed dense deposits suggesting fibronectin. A biopsy 134 d after the transplantation showed a feature of lobular glomerulonephritis corresponding FNG. The diagnosis was confirmed by IST4 positive and IST9 negative immunostaining together with typical fibrillary dense deposits in the mesangium and subendothelial spaces in electron microscopy. This is the first report of recurrent FNG in Japan.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747478     DOI: 10.1111/j.1399-0012.2012.01644.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  8 in total

1.  Hypertension and proteinuria-the needle in the haystack?: Answers.

Authors:  Michelle R Denburg; Lea F Surrey; Bruce R Pawel; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2015-05-28       Impact factor: 3.714

2.  Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).

Authors:  Bruce I Goldman; Bernard J Panner; Stephen L Welle; Matthew D Gross; Daniel A Gray
Journal:  CEN Case Rep       Date:  2021-04-10

3.  A Case of Fibronectin Glomerulopathy Caused by Missense Mutations in the Fibronectin 1 Gene.

Authors:  Shuma Hirashio; Yumi Yamada; Kouichi Mandai; Shigeo Hara; Takao Masaki
Journal:  Kidney Int Rep       Date:  2017-03-01

Review 4.  Fibronectin glomerulopathy complicated with persistent cloaca and congenital esophageal atresia: a case report and literature review.

Authors:  Misaki Takii; Takaichi Suehiro; Aya Shima; Hideki Yotsueda; Satoshi Hisano; Ritsuko Katafuchi
Journal:  BMC Nephrol       Date:  2017-09-06       Impact factor: 2.388

5.  A novel single amino acid deletion impairs fibronectin function and causes familial glomerulopathy with fibronectin deposits: case report of a family.

Authors:  Maria Luíza Gonçalves Dos Reis Monteiro; Fabiano Bichuette Custódio; Precil Diego Miranda de Menezes Neves; Frederico Moraes Ferreira; Elieser Hitoshi Watanabe; Antônio Marcondes Lerário; Liliane Silvano de Araújo; Bruno Eduardo Pedroso Balbo; Vívian Christine Dourado Pinto; Lívia Maria Gruli Barbosa; Vilmar de Paiva Marques; Juliana Reis Machado; Marlene Antônia Reis; Luiz Fernando Onuchic
Journal:  BMC Nephrol       Date:  2019-08-16       Impact factor: 2.388

6.  Case Report: Recurrent Deposition in Renal Allografts: A Rare Case of Fibronectin Glomerulopathy Overlooked in Native Kidneys.

Authors:  Xiaona Wei; Xiangdong Wang; Rui Zhang; Peifen Liang; Bo Liu; Lin Wang; Shuling Yue; Xiaojuan Li; Wenfang Chen; Qiongqiong Yang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

7.  A child with genetic FN1 mutation in the absence of classic glomerulopathy with fibronectin deposits(GFND) findings on biopsy.

Authors:  Xiao-Qing Yang; Tong Shen
Journal:  BMC Nephrol       Date:  2022-07-14       Impact factor: 2.585

8.  Extraglomerular Vascular Involvement of Glomerulopathy with Fibronectin Deposits.

Authors:  Masayuki Hara; Tetsuro Kusaba; Kenshi Ono; Naoko Masuzawa; Itaru Nakamura; Noriko Urata; Hirokazu Shiraishi; Shigeo Hara; Eiichi Konishi; Satoaki Matoba; Yayoi Shiotsu; Keiichi Tamagaki
Journal:  Intern Med       Date:  2021-02-08       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.